LIFEMD INC (LFMD) Stock Fundamental Analysis
NASDAQ:LFMD - Nasdaq - US53216B1044 - Common Stock - Currency: USD
Taking everything into account, LFMD scores 4 out of 10 in our fundamental rating. LFMD was compared to 37 industry peers in the Health Care Technology industry. LFMD may be in some trouble as it scores bad on both profitability and health. LFMD is not overvalued while it is showing excellent growth. This is an interesting combination.
1. Profitability
1.1 Basic Checks
LFMD had negative earnings in the past year.
LFMD had a positive operating cash flow in the past year.
LFMD had negative earnings in each of the past 5 years.
In multiple years LFMD reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -18.79%, LFMD is in line with its industry, outperforming 48.65% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -18.79% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
LFMD's Gross Margin of 87.99% is amongst the best of the industry. LFMD outperforms 94.59% of its industry peers.
In the last couple of years the Gross Margin of LFMD has grown nicely.
LFMD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.99% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
2. Health
2.1 Basic Checks
LFMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LFMD has more shares outstanding
Compared to 5 years ago, LFMD has more shares outstanding
LFMD has a better debt/assets ratio than last year.
2.2 Solvency
LFMD has an Altman-Z score of 1.89. This is not the best score and indicates that LFMD is in the grey zone with still only limited risk for bankruptcy at the moment.
LFMD's Altman-Z score of 1.89 is fine compared to the rest of the industry. LFMD outperforms 62.16% of its industry peers.
LFMD has a debt to FCF ratio of 5.81. This is a neutral value as LFMD would need 5.81 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 5.81, LFMD is doing good in the industry, outperforming 70.27% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 5.81 | ||
| Altman-Z | 1.89 |
ROIC/WACCN/A
WACC10.85%
2.3 Liquidity
LFMD has a Current Ratio of 0.82. This is a bad value and indicates that LFMD is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.82, LFMD is doing worse than 67.57% of the companies in the same industry.
LFMD has a Quick Ratio of 0.82. This is a bad value and indicates that LFMD is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of LFMD (0.77) is worse than 70.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.77 |
3. Growth
3.1 Past
LFMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.05%, which is quite impressive.
LFMD shows a strong growth in Revenue. In the last year, the Revenue has grown by 43.07%.
Measured over the past years, LFMD shows a very strong growth in Revenue. The Revenue has been growing by 76.23% on average per year.
EPS 1Y (TTM)54.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.26%
Revenue 1Y (TTM)43.07%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%48.83%
3.2 Future
The Earnings Per Share is expected to grow by 41.15% on average over the next years. This is a very strong growth
LFMD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 25.78% yearly.
EPS Next Y95.09%
EPS Next 2Y58.88%
EPS Next 3Y41.15%
EPS Next 5YN/A
Revenue Next Year31.3%
Revenue Next 2Y24.42%
Revenue Next 3Y25.78%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for LFMD. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 38.05, LFMD can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, LFMD is valued a bit cheaper than the industry average as 72.97% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 21.94. LFMD is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 38.05 |
4.2 Price Multiples
62.16% of the companies in the same industry are more expensive than LFMD, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LFMD indicates a somewhat cheap valuation: LFMD is cheaper than 62.16% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 149.91 | ||
| EV/EBITDA | 173.17 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LFMD's earnings are expected to grow with 41.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.88%
EPS Next 3Y41.15%
5. Dividend
5.1 Amount
LFMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
10.77
+0.13 (+1.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners37.55%
Inst Owner Change8.35%
Ins Owners15.43%
Ins Owner Change9.29%
Market Cap475.17M
Analysts81.33
Price Target12.24 (13.65%)
Short Float %14.93%
Short Ratio3.13
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-22.45%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)90.21%
Min EPS beat(2)61.87%
Max EPS beat(2)118.55%
EPS beat(4)2
Avg EPS beat(4)28.94%
Min EPS beat(4)-49.02%
Max EPS beat(4)118.55%
EPS beat(8)3
Avg EPS beat(8)-4.25%
EPS beat(12)5
Avg EPS beat(12)-13.27%
EPS beat(16)6
Avg EPS beat(16)-14.35%
Revenue beat(2)2
Avg Revenue beat(2)6.37%
Min Revenue beat(2)2.97%
Max Revenue beat(2)9.78%
Revenue beat(4)3
Avg Revenue beat(4)3.24%
Min Revenue beat(4)-2.71%
Max Revenue beat(4)9.78%
Revenue beat(8)6
Avg Revenue beat(8)2.84%
Revenue beat(12)7
Avg Revenue beat(12)0.03%
Revenue beat(16)7
Avg Revenue beat(16)-0.97%
PT rev (1m)-0.46%
PT rev (3m)2.37%
EPS NQ rev (1m)26.31%
EPS NQ rev (3m)33.33%
EPS NY rev (1m)53.33%
EPS NY rev (3m)35%
Revenue NQ rev (1m)0.43%
Revenue NQ rev (3m)4.61%
Revenue NY rev (1m)0.43%
Revenue NY rev (3m)4.97%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 38.05 | ||
| P/S | 2.03 | ||
| P/FCF | 149.91 | ||
| P/OCF | 30.9 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 173.17 |
EPS(TTM)-0.34
EYN/A
EPS(NY)0.28
Fwd EY2.63%
FCF(TTM)0.07
FCFY0.67%
OCF(TTM)0.35
OCFY3.24%
SpS5.3
BVpS-0.05
TBVpS-0.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -18.79% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.99% | ||
| FCFM | 1.35% |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
F-Score5
Asset Turnover3.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 5.81 | ||
| Debt/EBITDA | 2.6 | ||
| Cap/Depr | 121.5% | ||
| Cap/Sales | 5.22% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 587.29% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.77 | ||
| Altman-Z | 1.89 |
F-Score5
WACC10.85%
ROIC/WACCN/A
Cap/Depr(3y)162.46%
Cap/Depr(5y)195.18%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.26%
EPS Next Y95.09%
EPS Next 2Y58.88%
EPS Next 3Y41.15%
EPS Next 5YN/A
Revenue 1Y (TTM)43.07%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%48.83%
Revenue Next Year31.3%
Revenue Next 2Y24.42%
Revenue Next 3Y25.78%
Revenue Next 5YN/A
EBIT growth 1Y58.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year270.51%
EBIT Next 3Y74.07%
EBIT Next 5YN/A
FCF growth 1Y112.29%
FCF growth 3YN/A
FCF growth 5Y88.7%
OCF growth 1Y188.08%
OCF growth 3YN/A
OCF growth 5Y133.93%